Israel - English - Ministry of Health

inovamed pharma ltd, israel - entecavir as monohydrate - film coated tablets - entecavir as monohydrate 0.5 mg - entecavir - entecavir inovamed is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. - decompensated liver disease.

Israel - English - Ministry of Health

inovamed pharma ltd, israel - entecavir as monohydrate - film coated tablets - entecavir as monohydrate 1 mg - entecavir - entecavir inovamed is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. - decompensated liver disease.

Israel - English - Ministry of Health

inovamed pharma ltd, israel - pirfenidone - film coated tablets - pirfenidone 267 mg - pirfenidone - pirfenidone inovamed is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Israel - English - Ministry of Health

inovamed pharma ltd, israel - pirfenidone - film coated tablets - pirfenidone 801 mg - pirfenidone - pirfenidone inovamed is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Israel - English - Ministry of Health

inovamed ltd - ondansetron as hydrochloride dihydrate - film coated tablets - ondansetron as hydrochloride dihydrate 4 mg - ondansetron - adults : ondansetron inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for prevention and treatment of post operative nausea and vomiting (ponv).pediatric population : ondansetron inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.

Israel - English - Ministry of Health

inovamed ltd - ondansetron as hydrochloride dihydrate - film coated tablets - ondansetron as hydrochloride dihydrate 8 mg - ondansetron - adults : ondansetron inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for prevention and treatment of post operative nausea and vomiting (ponv).pediatric population : ondansetron inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.

Israel - English - Ministry of Health

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 10 mg - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension. - coronary heart disease (angina pectoris).

Israel - English - Ministry of Health

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 10 mg - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension. - coronary heart disease (angina pectoris).

Israel - English - Ministry of Health

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 2.5 mg - bisoprolol - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.

Israel - English - Ministry of Health

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 2.5 mg - bisoprolol - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.